New stent effective in complex coronary lesions:
This article was originally published in Clinica
A new intravascular rigid-flex stent is effective in patients with complex coronary legions where traditional stents cannot be used, researchers report. Investigators on the multinational FINESS trial deployed the new stent in 98% of lesions and said that early clinical outcome was promising and warranted a full-scale randomised trial, according to the Journal of the American College of Cardiology.
You may also be interested in...
The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.
Attorneys tell Medtech Insight a recent proposal to review regulations every 10 years could lift some burdens from the medical device industry, but warned that the full effects may not be seen for some time.
A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.